keyboard_arrow_up

JSB Market Research: PharmaPoint: Dry Eye Syndrome - Global Drug Forecast and Market Analysis to 2022

The Dry Eye Syndrome (DES) pipeline is strong, with 49 molecules in various phases of development. More notably, the late-stage pipeline has three products with novel mechanisms of action to treat the inflammation associated with the disease. That said, physicians suggest that the largest unmet need for DES treatment is diagnosis.

Browse Full Report @ http://www.jsbmarketresearch.com/healthcare-medical/r-PharmaPoint-Dry-Eye-Syndrome-Global-Drug-Forecast-and-Market-Analysis-118885

Scope

Annualized market revenues data for 9 key markets: US, France, Germany, Italy, Spain, UK, Japan, China, and India

Annualized market revenues data from 2012 to 2022 and forecast from 2012 to 2022

Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by the 9 key markets. Pipeline candidates fall under major therapeutic classes

Analysis of key recent licensing and partnership agreements in the DES Therapeutics market

Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications

Key topics covered include strategic competitor assessment, market characterization, unmet needs and implications.

Market Model Features

An interactive excel forecast model based on primary research interviews and surveys with KOLs and high-prescribing physicians is included in this report*. This patient based model provides diagnosis rates, patient segmentation, treatment rates, annual costs of therapy , and indication-specific drug sales for the 10 year forecast period. The forecast model is robust, fully transparent, and easy to navigate. Moreover, our models support data presented in the reports and the complete methodology is outlined in the report and the model.

*Model only available with site and global license purchases.

Key Findings

The global DES therapeutics market is forecast to reach $5.47 billion by 2022 due to the launch of novel pipeline drugs and an aging population.

The global push for increased physician and patient awareness will increase diagnosis and treatment.

By 2022, the DES market will be significantly more competitive, but the current dearth of treatment options leave much room for the coming pipeline therapies.

Table of Content:

2 Summary 8

 2.1 Significant growth is expected in the DES market from 2012-2022. 8
 
 2.2 Established players lack strong pipelines and will focus on filling this gap through acquisitions 10
 
 2.3 With only one drug on the market in the US and two in Japan, there is a significant void to fulfill with pipeline products 10
 
 2.4 The real opportunity for new players to market their new products and expand the patient base relies on improved diagnosis. 11
 
 2.5 Pipeline agents offer patients expansion into new markets, novel mechanisms of action and longer-acting delivery systems. 11
 
 2.6 What do the physicians think? 12
 
 3 Introduction 14
 
 3.1 Catalyst 14
 
 3.2 Related Reports 14
 
 4 Disease Overview 15
 
 4.1 Etiology and Pathophysiology 15
 
 4.1.1 Etiology 15
 
 4.1.2 Pathophysiology 16
 
 4.1.3 Classification 19
 
 4.1.4 Prognosis 19
 
 4.1.5 Quality of Life 20
 
 4.2 Symptoms 20
 
 5 Epidemiology 21
 
 5.1 Risk Factors and Comorbidities 21
 
 5.1.1 Risk of dry eye syndrome increases 35% each decade after age 40 22
 
 5.1.2 Women are twice as likely to have dry eye syndrome as men 22
 
 5.1.3 Use of certain medications may increase the risk of developing dry eye syndrome 23
 
 5.1.4 Diets rich in omega-3 fatty acids help prevent dry eye syndrome 24
 
 5.1.5 Certain environmental conditions can double the risk of dry eye syndrome 24
 
 5.2 Global Trends 24
 
 5.2.1 US 24
 
 5.2.2 5EU 25
 
 5.2.3 Asia 25
 
 5.3 Forecast Methodology 26
 
 5.3.1 Sources Used 26
 
 5.3.2 Forecast Assumptions and Methods 27
 
 5.3.3 Sources Not Used 29
 
 5.4 Epidemiology Forecast (2012–2022) 30
 
 5.4.1 Prevalent Cases of Dry Eye Syndrome 30
 
 5.4.2 Age-Specific Prevalent Cases 31
 
 5.4.3 Sex-Specific Prevalent Cases 34
 
 5.4.4 Age-Standardized Prevalence of Dry Eye Syndrome 35
 
 5.5 Discussion 36
 
 5.5.1 Conclusions on Epidemiology Trends 36
 
 5.5.2 Limitations of the Analysis 39
 
 5.5.3 Strengths of the Analysis 39
 
 6 Disease Management 39
 
 6.1 Overview 39
 
 6.1.1 Diagnosis Overview 39
 
 6.1.2 Treatment Guidelines 43
 
 6.1.3 Treatment Overview 47
 
 6.2 US 50
 
 6.2.1 Diagnosis 50
 
 6.2.2 Clinical Practice 51
 
 6.3 France 52
 
 6.3.1 Diagnosis 52
 
 6.3.2 Clinical Practice 53
 
 6.4 Germany 54
 
 6.4.1 Diagnosis 54
 
 6.4.2 Clinical Practice 54
 
 6.5 Italy 54
 
 6.5.1 Diagnosis 54
 
 6.5.2 Clinical Practice 54
 
 6.6 Spain 56
 
 6.6.1 Diagnosis 56
 
 6.6.2 Clinical Practice 56
 
 6.7 UK 57
 
 6.7.1 Diagnosis 57
 
 6.7.2 Clinical Practice 57
 
 6.8 Japan 57
 
 6.8.1 Diagnosis 57
 
 6.8.2 Clinical Practice 58
 
 6.9 China 60
 
 6.9.1 Diagnosis 60
 
 6.9.2 Clinical Practice 60
 
 6.10 India 61
 
 6.10.1 Diagnosis 61
 
 6.10.2 Clinical Practice 61

For More Related Market Research Reports click here

Chick-fil-A, Inc.: Foodservice - Company Profile and SWOT Report

Healthcare and Medical Market Research


About JSB Market Research -
JSB Market Research is one of the most significant databases of online market researches and intelligence reports and services. We specialize in providing market research reports for various industries. The online portal for marketing research deals with access to global market data and assists in providing expert insights and exposure on global companies, industries, products and trends.

Contact –
Tel: + 91 - 22 – 41236650
Website: http://www.jsbmarketresearch.com

Email - contact@jsbmarketresearch.com

Blog: http://www.jsbmarketresearch.com/blog/